Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Science
Quarraisha Abdool KarimCAPRISA 004 Trial Group

Abstract

The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of tenofovir, a nucleotide reverse transcriptase inhibitor, for the prevention of HIV acquisition in women. A double-blind, randomized controlled trial was conducted comparing tenofovir gel (n = 445 women) with placebo gel (n = 444 women) in sexually active, HIV-uninfected 18- to 40-year-old women in urban and rural KwaZulu-Natal, South Africa. HIV serostatus, safety, sexual behavior, and gel and condom use were assessed at monthly follow-up visits for 30 months. HIV incidence in the tenofovir gel arm was 5.6 per 100 women-years (person time of study observation) (38 out of 680.6 women-years) compared with 9.1 per 100 women-years (60 out of 660.7 women-years) in the placebo gel arm (incidence rate ratio = 0.61; P = 0.017). In high adherers (gel adherence > 80%), HIV incidence was 54% lower (P = 0.025) in the tenofovir gel arm. In intermediate adherers (gel adherence 50 to 80%) and low adherers (gel adherence < 50%), the HIV incidence reduction was 38 and 28%, respectively. Tenofovir gel reduced HIV acquisition by an estimated 39% overall, and by 54% in women with high gel adherenc...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Apr 1, 1990·American Journal of Public Health·Z A Stein
Mar 27, 2002·International Journal of Epidemiology·Quarraisha Abdool-Karim, Salim S Abdool-Karim
Jul 29, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B SchaafK Dalhoff
Mar 11, 2006·BMJ : British Medical Journal·Michael M CassellDavid Stanton
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Feb 25, 2010·AIDS·Nancy S PadianJudith N Wasserheit

❮ Previous
Next ❯

Citations

Jan 23, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R F O FrançaS O De Paula
Aug 31, 2011·AIDS and Behavior·Elizabeth E TolleyRewa Kohli
Feb 19, 2011·AIDS and Behavior·Susan P Buchbinder, Albert Liu
Feb 19, 2011·AIDS and Behavior·Ian McGowan
Mar 3, 2012·AIDS and Behavior·Mark J SiednerSheri D Weiser
Jul 5, 2012·AIDS and Behavior·Audrey PettiforMolly Rosenberg
Aug 16, 2012·AIDS and Behavior·Alex Carballo-DiéguezCurtis Dolezal
Jul 31, 2013·Journal of Materials Science. Materials in Medicine·Naghme Hajarol AsvadiAllan G A Coombes
Dec 25, 2010·Journal of Religion and Health·Hilda R Davis-Carroll
Mar 7, 2012·Pharmaceutical Research·Anthony S HamRobert W Buckheit
Oct 18, 2012·International Journal of Clinical Pharmacy·Christine Bruno, Parya Saberi
Feb 26, 2013·Bulletin of Mathematical Biology·Yuqin ZhaoYang Kuang
Jul 17, 2012·Journal of General Internal Medicine·Vagish HemmigeJohn A Schneider
Apr 17, 2013·Journal of General Internal Medicine·Elisa F Long, Robert R Stavert
Jan 20, 2009·Current HIV/AIDS Reports·Paul W Denton, J Victor Garcia
Sep 8, 2010·Current HIV/AIDS Reports·Kristen UnderhillKenneth H Mayer
Oct 14, 2010·Current HIV/AIDS Reports·Ann E KurthJudith N Wasserheit
Mar 23, 2011·Current HIV/AIDS Reports·Natasha A VermaMarla J Keller
Mar 30, 2011·Current HIV/AIDS Reports·Mark W Hull, Julio Montaner
Apr 6, 2011·Current HIV/AIDS Reports·Theodoros Kelesidis, Raphael J Landovitz
Oct 18, 2011·Current HIV/AIDS Reports·Douglas Krakower, Kenneth H Mayer
Mar 15, 2012·Current HIV/AIDS Reports·Kathryn CurranConnie Celum
Feb 2, 2013·Current HIV/AIDS Reports·Margaret L McNairyWafaa M El-Sadr
Mar 5, 2013·Current HIV/AIDS Reports·Sten H Vermund, Richard J Hayes
Apr 13, 2013·Current HIV/AIDS Reports·Catherine Hankins
Mar 16, 2013·Current HIV/AIDS Reports·Jared M Baeten, Robert Grant
Mar 26, 2013·Current HIV/AIDS Reports·Peter CherutichJonathan Mermin
Apr 9, 2013·Current HIV/AIDS Reports·Susan KaseddeUpjeet Chandan
Jun 26, 2013·Current HIV/AIDS Reports·Rochelle P Walensky
Aug 24, 2011·Current Infectious Disease Reports·Carolyn Gardella
Dec 7, 2011·Current Infectious Disease Reports·Bruce L GilliamZelalem Temesgen
Feb 22, 2012·Current Infectious Disease Reports·Charlene FlashKenneth H Mayer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.